5-BROMO-1H-PYRAZOLO[3,4-C]PYRIDINE-3-CARBOXYLIC ACID, 95%, 1g

1-Methylcyclobutanamine, 95.0%, 1g

2,2,2-Trifluoro-1-(3-nitrophenyl)ethanone, 95.0%, 1g

2,7-Diiodofluorene>98.0%(GC)5g

3-Amino-2-bromo-4-methylpyridine, 98.0%, 1g

Ethyl 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylate, 98%, 5g

3-CHLORO-4-NITROBENZALDEHYDE, 95.0%, 250mg

trans-beta-Styreneboronic acid, 95.0%, 1g

1-(Tetrahydro-2-furoyl)piperazine>97.0%(GC)5g

6-Maleimidohexanoic acid, 96.0%, 5g

4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide, 95%, 10mg

Oxalic acid solution, ROTI®Volum 0.05 mol/l - 0.1 N, ampoule, 1 piece, plastic packaging.

2'-O,4'-C-Methylenecytidine, 100mg